Health Catalyst (HCAT) Current Deferred Revenue (2018 - 2026)

Health Catalyst's Current Deferred Revenue history runs 9 years deep, the most recent figure standing at $70.0 million for Q1 2026.

• Quarterly Current Deferred Revenue fell 2.09% year-over-year to $70.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $70.0 million (down 2.09% YoY) and the FY2025 annual result came in at $56.5 million, up 5.61% from the prior year.
• Current Deferred Revenue was $70.0 million for Q1 2026 at Health Catalyst, up from $56.5 million in the prior quarter.
• Across five years, Current Deferred Revenue topped out at $71.5 million in Q1 2025 and bottomed at $52.2 million in Q3 2024.
• A 5-year average of $59.9 million and a median of $59.2 million in 2025 frame the typical range for Current Deferred Revenue.
• Annual changes were most pronounced in 2022 — Current Deferred Revenue advanced 19.69% — and 2023, when it decreased 5.88%.
• Health Catalyst's Current Deferred Revenue stood at $55.0 million in 2022, then grew by 1.53% to $55.8 million in 2023, then fell by 4.12% to $53.5 million in 2024, then grew by 5.61% to $56.5 million in 2025, then climbed by 23.89% to $70.0 million in 2026.
• Business Quant data shows HCAT's Current Deferred Revenue at $70.0 million in Q1 2026, $56.5 million in Q4 2025, and $59.2 million in Q3 2025.